Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.

Herve Tiriac

Title(s)Assistant Researcher, Surgery
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
Emailhtiriac@ucsd.edu
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Selective targeting of NRF2-high pancreatic ductal adenocarcinoma with an NQO1-activatable prodrug. Proc Natl Acad Sci U S A. 2026 Jan 27; 123(4):e2511733123. Antonucci L, Watari K, Feng Y, Qi J, Zhu M, Wang T, Ng I, Vucic EA, Riahi I, Huang L, Hosseini M, Mose E, French R, Weitz J, Bar-Sagi D, Dawson DW, Sun B, Tiriac H, Xu J, Xu S, Lowy AM, Karin M. PMID: 41564125; PMCID: PMC12849708.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    2. Chronic pancreatitis patient-derived organoids reveal new paths to precision therapeutics. bioRxiv. 2025 Nov 14. Osorio-Vasquez V, Zhu J, Lumibao JC, Lande K, Peck KL, Stamp MK, Okhovat SR, Song H, Ogawa S, Kubota C, Pantazopoulou V, Dai Y, Rock A, Bottomley C, Thomas E, Hsu J, Morales AH, Fowler A, McGriff T, Evensen KG, Larsen S, Abdulla M, Greer P, Gibson J, Downes M, Evans R, Lowy AM, Whitcomb DC, Zou J, Molinolo A, Oh TG, White R, Bellin M, Tiriac H, Engle DD. PMID: 41279927; PMCID: PMC12633304.
      View in: PubMed   Mentions:
    3. Mevalonate Biosynthesis is a Metabolic Vulnerability of Gemcitabine-resistant Pancreatic Cancer. bioRxiv. 2025 Sep 20. Beutel AK, Calderon S, Nghiem E, Gulay K, Santana LPS, Zimmer E, Singh R, Anaraki C, Yousefian N, Allgöwer C, Tong G, Geller C, Chao A, Juarez D, Seufferlein T, Muir A, Jang C, Edinger AL, Seldin M, Martinez TF, Kleger A, Chang DK, Tiriac H, Valerin JB, Fruman DA, Halbrook CJ. PMID: 41000736; PMCID: PMC12458164.
      View in: PubMed   Mentions:
    4. Experimental models of pancreas cancer: what has been the impact for precision medicine? J Clin Invest. 2025 Aug 15; 135(16). Pantazopoulou V, Kubota CS, Ogawa S, Gulay KCM, Lin X, Song H, Weitz JR, Tiriac H, Lowy AM, Engle DD. PMID: 40829173; PMCID: PMC12352895.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    5. ZBTB11 depletion targets metabolic vulnerabilities in KRAS inhibitor-resistant PDAC. Nat Chem Biol. 2026 Feb; 22(2):260-273. Tran NL, Jiang J, Ma M, Gadbois GE, Gulay KCM, Verano AL, Schiavon CR, Rebollo E, Zhou H, Huang CT, Murad R, Scott DA, Manor U, Bang AG, Tiriac H, Lowy AM, Wang ES, Ferguson FM. PMID: 40789946.
      View in: PubMed   Mentions:    Fields:    
    6. Leveraging autophagy and pyrimidine metabolism to target pancreatic cancer. bioRxiv. 2025 Jun 05. Dufresne S, Kuna RS, Wong K, Komarla A, Rock A, Rosada-Encarnación J, Shen C, Mondal P, Parham LR, Izidro Layng F, Peck KL, Fowler A, Lowy AM, Engle D, Tiriac H, Shaw R, Cosford N, Metallo C, Towers C. PMID: 40501952; PMCID: PMC12154929.
      View in: PubMed   Mentions:
    7. Spatial mapping of transcriptomic plasticity in metastatic pancreatic cancer. Nature. 2025 Jun; 642(8066):212-221. Pei G, Min J, Rajapakshe KI, Branchi V, Liu Y, Selvanesan BC, Thege F, Sadeghian D, Zhang D, Cho KS, Chu Y, Dai E, Han G, Li M, Yee C, Takahashi K, Garg B, Tiriac H, Bernard V, Semaan A, Grem JL, Caffrey TC, Burks JK, Lowy AM, Aguirre AJ, Grandgenett PM, Hollingsworth MA, Guerrero PA, Wang L, Maitra A. PMID: 40269162.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    8. Histamine H1 Receptor: A potential therapeutic target for pancreatic ductal adenocarcinoma. J Pharmacol Exp Ther. 2025 May; 392(5):103573. Salmerón C, Tomás Bort E, Sriram K, Javadi-Paydar M, Smitham JE, Pham K, Grose RP, McCormick PJ, DiNardo A, Weitz J, Tiriac H, Lowy AM, Insel PA. PMID: 40288207.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    9. MICAL2 Promotes Pancreatic Cancer Growth and Metastasis. Cancer Res. 2025 Mar 14; 85(6):1049-1063. Garg B, Khan S, Courelli AS, Panneerpandian P, Sheik Pran Babu D, Mose ES, Gulay KCM, Sharma S, Sood D, Wenzel AT, Martsinkovskiy A, Rajbhandari N, Patel J, Jaquish D, Esparza E, Jaque K, Aggarwal N, Lambies G, D'Ippolito A, Austgen K, Johnston B, Orlando DA, Jang GH, Gallinger S, Goodfellow E, Brodt P, Commisso C, Tamayo P, Mesirov JP, Tiriac H, Lowy AM. PMID: 39745352; PMCID: PMC11907191.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    10. Cyclin-Dependent Kinase 4/6 Inhibition as a Novel Therapy for Peritoneal Mucinous Carcinomatosis With GNAS Mutations. J Clin Oncol. 2025 Feb 20; 43(6):705-715. Weitz J, Nishizaki D, Liau J, Patel J, Ng I, Sun S, Ramms D, Zou J, Wishart B, Rull J, Baumgartner J, Kelly K, White R, Veerapong J, Hosseini M, Patel H, Botta G, Gutkind JS, Tiriac H, Kato S, Lowy AM. PMID: 39413348; PMCID: PMC11829827.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    11. MICAL2 Is a Super Enhancer Associated Gene that Promotes Pancreatic Cancer Growth and Metastasis. bioRxiv. 2024 Jun 30. Garg B, Khan S, Babu DS, Mose E, Gulay K, Sharma S, Sood D, Wenzel AT, Martsinkovskiy A, Patel J, Jaquish D, Lambies G, D'Ippolito A, Austgen K, Johnston B, Orlando D, Jang GH, Gallinger S, Goodfellow E, Brodt P, Commisso C, Tamayo P, Mesirov JP, Tiriac H, Lowy AM. PMID: 38979336; PMCID: PMC11230455.
      View in: PubMed   Mentions:
    12. ZBTB11 Depletion Targets Metabolic Vulnerabilities in K-Ras Inhibitor Resistant PDAC. bioRxiv. 2024 May 21. Tran NL, Jiang J, Ma M, Gadbois GE, Gulay KCM, Verano A, Zhou H, Huang CT, Scott DA, Bang AG, Tiriac H, Lowy AM, Wang ES, Ferguson FM. PMID: 38826238; PMCID: PMC11142081.
      View in: PubMed   Mentions:
    13. The novel drug candidate S2/IAPinh improves survival in models of pancreatic and ovarian cancer. Sci Rep. 2024 03 16; 14(1):6373. Hagi T, Vangveravong S, Takchi R, Gong Q, Goedegebuure SP, Tiriac H, Van Tine BA, Powell MA, Hawkins WG, Spitzer D. PMID: 38493257; PMCID: PMC10944456.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    14. The effect of extracellular matrix on the precision medicine utility of pancreatic cancer patient-derived organoids. JCI Insight. 2024 01 09; 9(1). Lumibao JC, Okhovat SR, Peck KL, Lin X, Lande K, Yomtoubian S, Ng I, Tiriac H, Lowy AM, Zou J, Engle DD. PMID: 38051586; PMCID: PMC10906458.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    15. Engrailed-1 Promotes Pancreatic Cancer Metastasis. Adv Sci (Weinh). 2024 02; 11(6):e2308537. Xu J, Roe JS, Lee E, Tonelli C, Ji KY, Younis OW, Somervile TDD, Yao M, Milazzo JP, Tiriac H, Kolarzyk AM, Lee E, Grem JL, Lazenby AJ, Grunkemeyer JA, Hollingsworth MA, Grandgenett PM, Borowsky AD, Park Y, Vakoc CR, Tuveson DA, Hwang CI. PMID: 38110836; PMCID: PMC10853725.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    16. Pancreatic ductal adenocarcinoma induces neural injury that promotes a transcriptomic and functional repair signature by peripheral neuroglia. Oncogene. 2023 08; 42(34):2536-2546. Weitz J, Garg B, Martsinkovskiy A, Patel S, Tiriac H, Lowy AM. PMID: 37433986; PMCID: PMC10880465.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    17. Pancreatic Ductal Adenocarcinoma Induces Neural Injury that Promotes a Transcriptomic and Functional Repair Signature by Peripheral Neuroglia. Res Sq. 2023 Mar 28. Weitz J, Garg B, Tiriac H, Martsinkovskiy A, Patel S, Lowy A. PMID: 37034696; PMCID: PMC10081383.
      View in: PubMed   Mentions:
    18. Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic immune responses that inhibit liver metastasis in an orthotopic model. J Immunother Cancer. 2023 01; 11(1). Shankara Narayanan JS, Hayashi T, Erdem S, McArdle S, Tiriac H, Ray P, Pu M, Mikulski Z, Miller A, Messer K, Carson D, Schoenberger S, White RR. PMID: 36634919; PMCID: PMC9843215.
      View in: PubMed   Mentions: 15     Fields:    Translation:Animals
    19. Culture and Imaging of Ex Vivo Organotypic Pseudomyxoma Peritonei Tumor Slices from Resected Human Tumor Specimens. J Vis Exp. 2022 12 09; (190). Weitz J, Montecillo Gulay KC, Hurtado de Mendoza T, Tiriac H, Baumgartner J, Kelly K, Veerapong J, Lowy AM. PMID: 36571414; PMCID: PMC10880464.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    20. An Ex Vivo Organotypic Culture Platform for Functional Interrogation of Human Appendiceal Cancer Reveals a Prominent and Heterogenous Immunological Landscape. Clin Cancer Res. 2022 11 01; 28(21):4793-4806. Weitz J, Hurtado de Mendoza T, Tiriac H, Lee J, Sun S, Garg B, Patel J, Li K, Baumgartner J, Kelly KJ, Veerapong J, Hosseini M, Chen Y, Lowy AM. PMID: 36067351.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimals
    21. Patient-Derived Sarcoma Organoids Offer a Novel Platform for Personalized Precision Medicine. Ann Surg Oncol. 2022 11; 29(12):7239-7241. Sanchez-Fdez A, Sharma AK, Tiriac H, Sicklick JK. PMID: 35831519; PMCID: PMC10173699.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    22. Using Organotypic Tissue Slices to Investigate the Microenvironment of Pancreatic Cancer: Pharmacotyping and Beyond. Cancers (Basel). 2021 Oct 05; 13(19). Weitz JR, Tiriac H, Hurtado de Mendoza T, Wascher A, Lowy AM. PMID: 34638476; PMCID: PMC8507648.
      View in: PubMed   Mentions: 12  
    23. Vestigial-like 1 is a shared targetable cancer-placenta antigen expressed by pancreatic and basal-like breast cancers. Nat Commun. 2020 10 21; 11(1):5332. Bradley SD, Talukder AH, Lai I, Davis R, Alvarez H, Tiriac H, Zhang M, Chiu Y, Melendez B, Jackson KR, Katailiha A, Sonnemann HM, Li F, Kang Y, Qiao N, Pan BF, Lorenzi PL, Hurd M, Mittendorf EA, Peterson CB, Javle M, Bristow C, Kim M, Tuveson DA, Hawke D, Kopetz S, Wolff RA, Hwu P, Maitra A, Roszik J, Yee C, Lizée G. PMID: 33087697; PMCID: PMC7577998.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    24. Isolation and Characterization of Patient-derived Pancreatic Ductal Adenocarcinoma Organoid Models. J Vis Exp. 2020 01 14; (155). Tiriac H, French R, Lowy AM. PMID: 32009658.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    25. Organoid models for translational pancreatic cancer research. Curr Opin Genet Dev. 2019 02; 54:7-11. Tiriac H, Plenker D, Baker LA, Tuveson DA. PMID: 30844513; PMCID: PMC6722026.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    26. Successful creation of pancreatic cancer organoids by means of EUS-guided fine-needle biopsy sampling for personalized cancer treatment. Gastrointest Endosc. 2018 Jun; 87(6):1474-1480. Tiriac H, Bucobo JC, Tzimas D, Grewel S, Lacomb JF, Rowehl LM, Nagula S, Wu M, Kim J, Sasson A, Vignesh S, Martello L, Munoz-Sagastibelza M, Somma J, Tuveson DA, Li E, Buscaglia JM. PMID: 29325707; PMCID: PMC6143289.
      View in: PubMed   Mentions: 99     Fields:    Translation:HumansCells
    27. NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic Cancer. Cell. 2016 Aug 11; 166(4):963-976. Chio IIC, Jafarnejad SM, Ponz-Sarvise M, Park Y, Rivera K, Palm W, Wilson J, Sangar V, Hao Y, Öhlund D, Wright K, Filippini D, Lee EJ, Da Silva B, Schoepfer C, Wilkinson JE, Buscaglia JM, DeNicola GM, Tiriac H, Hammell M, Crawford HC, Schmidt EE, Thompson CB, Pappin DJ, Sonenberg N, Tuveson DA. PMID: 27477511; PMCID: PMC5234705.
      View in: PubMed   Mentions: 230     Fields:    Translation:HumansAnimalsCells
    28. Conjugation to the sigma-2 ligand SV119 overcomes uptake blockade and converts dm-Erastin into a potent pancreatic cancer therapeutic. Oncotarget. 2016 Jun 07; 7(23):33529-41. Ohman KA, Hashim YM, Vangveravong S, Nywening TM, Cullinan DR, Goedegebuure SP, Liu J, Van Tine BA, Tiriac H, Tuveson DA, DeNardo DG, Spitzer D, Mach RH, Hawkins WG. PMID: 27244881; PMCID: PMC5085100.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    29. Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy. Cell. 2014 Sep 25; 159(1):80-93. Sherman MH, Yu RT, Engle DD, Ding N, Atkins AR, Tiriac H, Collisson EA, Connor F, Van Dyke T, Kozlov S, Martin P, Tseng TW, Dawson DW, Donahue TR, Masamune A, Shimosegawa T, Apte MV, Wilson JS, Ng B, Lau SL, Gunton JE, Wahl GM, Hunter T, Drebin JA, O'Dwyer PJ, Liddle C, Tuveson DA, Downes M, Evans RM. PMID: 25259922; PMCID: PMC4177038.
      View in: PubMed   Mentions: 627     Fields:    Translation:HumansAnimalsCells
    Herve's Networks
    Concepts (111)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (54)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-21-g9d46e6c4 on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California